DPDoctor's PassportEducation
Educational draft · awaiting clinical reviewThe full textbook explains uncertainty but does not replace live national or local guidance, specialist advice, or current prescribing information.
Full textbookMLAMSRAFoundation

Disorders of thirst and hypothalamic function

Distinguish impaired thirst, primary polydipsia and broader hypothalamic dysfunction, then build supervised water, endocrine and neurobehavioural safety plans.

!
Loss of thirst removes the defence against hypernatraemia

Adipsia with AVP deficiency can produce profound hypernatraemic dehydration without the expected complaint of thirst. Compulsive or hypothalamic excess drinking can instead cause acute hyponatraemia, cerebral oedema and seizure. Altered consciousness, major sodium disturbance, hypothermia or hyperthermia requires acute monitored care.

Action: Assess ABCDE, bedside glucose, temperature, volume status, measured sodium and osmolality, urine output and urine osmolality. Correct water and sodium at a controlled syndrome-specific rate, protect cortisol physiology when pituitary disease is possible, and involve endocrinology and neuroscience services early.

Open the sections you need. The overview is shown first.
01OverviewDefinition, clinical context and the essential points that orientate the chapter.

Osmoreceptors in the anterior hypothalamus coordinate thirst with AVP release, while wider hypothalamic networks regulate appetite, energy expenditure, temperature, autonomic output, sleep and pituitary releasing hormones. A craniopharyngioma, germinoma, infiltrative disease, inflammation, trauma, vascular injury, radiotherapy or surgery can therefore produce much more than an isolated hormone deficit. Take a chronological history of fluid behaviour, documented urine volume, nocturia, sodium episodes, access to water, cognition, sleep, temperature tolerance, weight and appetite. Ask relatives or carers when insight is impaired. Examine hydration, orthostatic blood pressure, visual fields, cognition and neurological function, and review the full pituitary axis. A stable normal sodium does not prove intact osmoregulation if a rigid routine or carer support is compensating.

The water-balance differential begins with measured plasma and urine tonicity. In primary polydipsia, low plasma tonicity suppresses AVP and urine becomes dilute; restriction of excess intake may restore balance, but abrupt unsupervised restriction can be unsafe until AVP deficiency is excluded. In adipsic AVP deficiency, urine is dilute while thirst fails to respond as sodium rises. Treatment may require a fixed daily desmopressin schedule, prescribed water intake, daily weight targets and sodium surveillance designed by a specialist centre. Broader hypothalamic dysfunction needs coordinated endocrine, dietetic, sleep, neuropsychological, rehabilitation and safeguarding input. Hypothalamic obesity is not simply lack of willpower: altered satiety and energy expenditure after structural injury can produce rapid weight gain despite intensive lifestyle effort. Local services and evidence for specialist pharmacotherapy vary, so treatment should be transparent about uncertainty and access.

Key points

  • Thirst and AVP secretion are separate hypothalamic responses to tonicity; losing one but not the other creates distinctive risk.
  • Adipsia means absent or inadequate thirst despite a physiological stimulus and is particularly dangerous when central AVP deficiency coexists.
  • Primary polydipsia suppresses AVP appropriately and produces very dilute urine; chronic excess intake can blur dynamic testing by reducing renal concentrating capacity.
  • Before attributing thirst to behaviour, exclude hyperglycaemia, hypercalcaemia, hypokalaemia, diuretics, kidney disease and true AVP deficiency.
  • Hypothalamic lesions may also disturb appetite, weight, temperature, sleep-wake rhythm, autonomic regulation, memory, behaviour and several pituitary axes.
  • A supervised fixed-fluid and desmopressin plan may be necessary when thirst is unreliable; telling an adipsic patient simply to drink to thirst is unsafe.
  • Psychiatric illness and medicines can contribute to polydipsia, but diagnostic language must remain non-stigmatising and follow measured physiology.
  • Rapid weight change, urine output and sodium trend often reveal water imbalance earlier than a patient with cognitive or thirst impairment can report symptoms.
02AetiologyUnderlying causes, associations and risk factors, with why each one matters.
01

Structural hypothalamic injury

Tumour, inflammation, infiltration, trauma, vascular injury, radiotherapy or surgery can disrupt thirst, vasopressin, appetite, temperature, sleep and pituitary regulation together.

02

Primary polydipsia

Behavioural or psychiatric excess drinking lowers plasma tonicity and suppresses vasopressin, producing dilute urine without a primary hormone-release defect.

03

Adipsic vasopressin deficiency

Combined loss of vasopressin and thirst removes both renal conservation and behavioural water replacement, creating exceptional sodium instability.

03PathophysiologyThe causal sequence from the underlying abnormality to symptoms and harm.
  1. 1
    Osmosensing becomes abnormal

    Damaged hypothalamic osmoreceptors may fail to coordinate rising plasma tonicity with appropriate thirst and vasopressin release.

  2. 2
    Water intake and output uncouple

    Excess drinking can overwhelm renal excretion, while absent thirst plus dilute polyuria allows unopposed free-water loss and hypernatraemia.

  3. 3
    Wider hypothalamic networks fail

    Injury may also disturb satiety, energy expenditure, autonomic output, temperature and sleep, producing multisystem disability beyond water balance.

04Clinical features and red flagsSymptoms, examination findings, patterns of presentation and time-critical warnings.
Adipsic hypernatraemia

High sodium, dehydration and scant thirst after anterior hypothalamic injury suggests failure of the thirst response, with or without concurrent AVP deficiency.

Primary polydipsia

Persistent high intake, low or low-normal plasma osmolality and appropriately dilute urine support excess drinking; confirm physiology before using a psychiatric attribution.

Hypothalamic obesity

Rapid disproportionate weight gain, hyperphagia, low energy expenditure or autonomic features after hypothalamic tumour or treatment suggests acquired regulatory injury.

Thermoregulatory failure

Unexplained recurrent hypothermia, hyperthermia or absent normal temperature response after a central lesion requires exclusion of infection, thyroid and adrenal disease before hypothalamic attribution.

Multi-domain dysfunction

Sleep reversal, behavioural change, memory impairment, autonomic instability, appetite disturbance, visual symptoms and multiple pituitary deficits indicate a structural rather than isolated water-behaviour problem.

05InvestigationsWhat to request, why it matters and how to interpret it.
Investigation order

Read from the initial assessment onwards. Tests may run in parallel in urgent care; first-line, preferred, confirmatory, definitive and gold-standard labels appear only when the chapter explicitly states them.

  1. 01
    Fluid and urine-volume diaryFirst step
    Why
    Quantify drinking, nocturia and urine output against timing of symptoms, medicines and caregiver support.
    Interpretation and limitations
    High intake preceding output supports polydipsia, while output that drives relentless thirst suggests a renal water-loss process; diaries can be unreliable when cognition is impaired.
  2. 02
    Paired plasma and urine osmolality with sodium
    Why
    Determine whether renal water excretion and thirst are appropriate for circulating tonicity.
    Interpretation and limitations
    Dilute urine with low plasma osmolality fits suppressed AVP during excess intake; dilute urine with high sodium indicates impaired AVP action, and absent thirst localises additional hypothalamic dysfunction.
  3. 03
    Glucose, calcium, potassium and renal function
    Why
    Exclude osmotic diuresis and metabolic causes of thirst or impaired urinary concentration.
    Interpretation and limitations
    Treating hyperglycaemia, hypercalcaemia, hypokalaemia or kidney disease may resolve the water symptom and prevents misleading dynamic testing.
  4. 04
    Specialist dynamic AVP or copeptin assessment
    Why
    Separate primary polydipsia, AVP deficiency and AVP resistance when basal physiology is equivocal.
    Interpretation and limitations
    Use a validated supervised protocol with explicit stop criteria; chronic polydipsia can attenuate concentrating ability, so results require expert context rather than a single urine cut-off.
  5. 05
    Pituitary MRI with visual assessment
    Why
    Identify hypothalamic, stalk or sellar pathology and its relation to optic structures.
    Interpretation and limitations
    A mass, stalk change or treatment effect requires multidisciplinary review; imaging findings must be integrated with full pituitary and neurological function.
  6. 06
    Comprehensive pituitary and hypothalamic review
    Why
    Assess cortisol, thyroid, gonadal and growth axes plus sleep, temperature, cognition, appetite and autonomic function.
    Interpretation and limitations
    Multiple abnormalities strengthen a central structural diagnosis and determine treatment sequence, particularly glucocorticoid protection before thyroid replacement.
06Differential diagnosisRealistic alternatives and the features that help distinguish them.
01

Osmotic diuresis

Glycosuria, high urea or diuretics cause polyuria with appreciable urine solute rather than the very dilute output expected from impaired vasopressin action.

02

Nephrogenic diabetes insipidus

Renal resistance from lithium, electrolyte disturbance or kidney disease produces dilute polyuria despite preserved vasopressin production and thirst.

03

Compensated normal water balance

A normal sodium may reflect rigid prescribed drinking or carer support rather than intact osmoregulation; history and paired plasma-urine testing reveal the dependence.

04

Urinary tract disorder

Frequency from bladder disease produces small voids rather than documented high-volume urine, separating it from a hypothalamic water-balance syndrome.

07ManagementImmediate care, first-line treatment, alternatives and escalation.
01Water phenotypeDefine what drives drinking and urineFirst stepThirst, high intake, urinary frequency or recurrent dysnatraemia lacks a clear cause.
  1. 1Measure true urine volume and construct a timed intake-output history with family or carers where insight or memory may be limited.
  2. 2Check paired plasma and urine tonicity plus glucose, calcium, potassium, kidney function and relevant medicines before imposing fluid change.
  3. 3Refer equivocal hypotonic polyuria for supervised dynamic testing, explicitly documenting whether thirst rose appropriately during the stimulus.
02AdipsiaReplace automatic thirst with a planThirst is absent or unreliable during high sodium or confirmed central AVP deficiency.
  1. 1Agree a specialist fixed desmopressin and daily water prescription linked to a target weight or sodium algorithm, rather than drinking to subjective thirst.
  2. 2Train the person and carers to record weight, intake, urine and illness, with a named service for same-day advice when targets deviate.
  3. 3Adapt the plan for heat, fever, vomiting, fasting and reduced consciousness, arranging urgent assessment whenever safe oral water or monitoring cannot be maintained.
03Whole hypothalamusCoordinate multi-system rehabilitationA hypothalamic lesion affects weight, sleep, temperature, behaviour, cognition or several pituitary axes.
  1. 1Map each deficit objectively and treat time-critical hormone replacement in safe order while reviewing tumour activity and visual function.
  2. 2Bring together endocrinology, dietetics, sleep medicine, neuropsychology, rehabilitation and social support with goals based on function and quality of life.
  3. 3Review safeguarding, capacity, school or work adjustments and caregiver burden, because treatment success depends on reliable daily execution beyond prescriptions.
Key medicines and prescribing safety1 treatment · regimens, roles and cautions
Replaces absent AVP action when thirst cannot protect against renal free-water loss.

Desmopressin in adipsic AVP deficiency

Use the formulation-specific fixed regimen designed by the specialist centre, coordinated with a prescribed daily water intake and weight or sodium adjustment rule rather than unsupervised symptom dosing.

Both omission and over-treatment can be rapidly dangerous. Cognitive impairment increases dosing error, formulations are not interchangeable, and illness or altered intake requires immediate plan review.

08ComplicationsImportant consequences, why they occur and why they matter clinically.
01

Severe dysnatraemia

Uncontrolled water loss causes hypernatraemic dehydration, while excess intake with impaired excretion causes hyponatraemia, confusion, seizure or coma.

02

Hypothalamic obesity

Altered satiety and reduced energy expenditure after structural injury can cause rapid weight gain despite substantial lifestyle effort.

03

Dependence and safeguarding risk

Cognitive, behavioural or mobility impairment may make safe water intake dependent on carers and reliable access, increasing vulnerability during transitions or admission.

09Monitoring and follow-upTreatment response, safety checks and longer-term review.
  • Record daily weight at a consistent time, with agreed upper and lower action points representing likely water retention or deficit.
  • Measure sodium at the specialist-defined interval and urgently after illness, unexpected weight change, altered urine output or any neurological symptom.
  • Track temperature, sleep pattern, appetite, functional activity and behaviour longitudinally rather than reducing follow-up to pituitary blood tests.
  • Review all hormone replacements after weight change, surgery or new medicines and maintain emergency steroid safety where ACTH deficiency coexists.
  • Reassess the practicality of the care plan and carer capacity, simplifying measurements or administration when complexity itself creates risk.
10Special situationsVariants, exceptions and circumstances that change the usual approach.

Two osmostats can dissociate

Thirst and AVP usually activate together but occupy separable pathways. A lesion may abolish drinking while leaving partial renal concentration, or remove both.

Behaviour has physiology

Primary polydipsia changes medullary concentration and AVP dynamics over time. Its biological effects explain why simple labels and abrupt restriction are unreliable.

Carers are part of treatment

In adipsia, remembering a water prescription is as lifesaving as taking desmopressin. Training, respite and contingency planning are clinical interventions.

Hypothalamic obesity is distinct

Damage can reduce energy expenditure and satiety signalling. Advising generic willpower without acknowledging the lesion undermines care and misses specialist options.

Temperature needs context

Central dysregulation is possible, but infection, adrenal crisis, thyroid disease and medicine effects remain more urgent exclusions during any acute episode.

11Common pitfallsFrequent interpretation and management errors.
  1. 01

    Telling a person with documented adipsia to drink to thirst when the relevant sensation is absent.

  2. 02

    Diagnosing psychogenic polydipsia before excluding glucose, electrolytes, kidney disease and AVP disorders.

  3. 03

    Performing unsupervised water restriction in uncertain hypotonic polyuria.

  4. 04

    Treating hypothalamic weight gain as non-adherence without assessing satiety, sleep and energy regulation.

  5. 05

    Monitoring only sodium while missing cortisol deficiency, visual decline or tumour recurrence.

  6. 06

    Designing a complex daily plan without confirming cognition, support and a backup caregiver.

Practice

Two practice questions

Question 1 of 20 correct
Endocrinology and metabolismOriginal SBA

Absent thirst with hypernatraemia

A patient after craniopharyngioma surgery repeatedly develops hypernatraemia and dilute polyuria but reports no thirst even when clinically dehydrated. Which long-term strategy is most appropriate?

Sources and review status4 sources · checked 27 Aug 2026 · clinical review pending
Sources

Sources and review status

National guidance is shown before implementation-dependent detail. Typical adult dose examples remain subject to patient factors, contraindications and the live BNF or specialist protocol. Source check completed 27 Aug 2026; clinical approval remains outstanding.

Authoring stateComplete draftClinical stateAwaiting reviewJurisdictionUnited Kingdom